Organization
H. Lundbeck A/S
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
H. Lundbeck A/S
... get involved: Back by popular demand! Join our round table sessions with Lundbeck, CSL Behring, OPKO biologics and Cheisi on key topics facing the industry ...
... How quickly fortunes change. Last quarter, Lundbeck's then CEO Kåre Schultz got to report that the Danish drugmaker had ...
... Takeda Pharmaceuticals U.S.A., Inc. (Takeda), Lundbeck U.S. and Advocate Health Care today announced a collaboration focusing on the ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the completed trials were announced May ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the two completed trials were announced ...
... clinical trials for the agitation indication that were completed by Otsuka and Lundbeck earlier this year. Top-line results for the two completed trials were announced ...
... of Social Media Gold Digitas Health HealthySexual Silver Klick, McCann HumanCare, and Takeda/Lundbeck for Trintellix Lighter Blue Best Digital Initiative for Non-Consumers Gold Hive Health ...
... Otsuka and Lundbeck today announce the submission by Otsuka of a new drug application (NDA) ...
... Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 ...
... Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 ...
... to power their next generation global clinical trials. The continued partnership allows Lundbeck to leverage integral parts of the Medidata Clinical Cloud platform that provide ...
... with The Times of Israel. RELATED:Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz Landa, who has for years pushed the drugmaker ...
... through the transactions by the end of the year. RELATED: Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid ...
... is finally over. The generics giant, in a volatile financial situation, hopes Lundbeck chief Kåre Schultz can work his magic again just as he did ...
... disease. The collaboration is focused on using [F-18]MK-6240 as a biomarker in Lundbeck neurodegenerative disease research studies. The parties will collaborate to evaluate ways to ...
... Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck U.S. today announced upcoming data presentations reinforcing the long-term safety and efficacy ...
... CEO. The search team was well aware of that fact and lured Lundbeck chief Kåre Schultz with a handsome offer that makes him one of ...
... the $40 billion acquisition of Allergan s generics business in 2015. At Lundbeck, Schultz, 56, is credited with leading a restructuring and turnaround strategy that ...
... Drug maker Teva has poached rival Lundbeck's Kåre Schultz to serve as its chief executive. AstraZeneca's CEO Pascal Soriot ...
... at least $2 billion. RELATED: Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz It’ll be up to the company’s new helmsman, ...
... as the company hinted it would, it’s poached him from another drugmaker. Lundbeck head honcho Kåre Schultz, a longtime Novo Nordisk vet, will be stepping ...
... Valby, Denmark - Valby, Denmark - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons ...
... listed on NASDAQ OMX Copenhagen after registration with the Danish Business Authority. Lundbeck's current share capital amounts to DKK 992,302,945. Tel: +45 30 83 24 ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤